Intercept Pharmaceuticals, Inc.: accounts_payable
| Value | {"amount": 6922000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2018-09-30) |
| Status | current |
| Entity | Intercept Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:06:47.985899+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/133b490b-0c0f-4314-8735-e5f449698365
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-18-056834 · Open the official SEC filing →Retrieved: 2026-08-19T12:06:47.985899+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001270073/accounts-payable/2018-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/133b490b-0c0f-4314-8735-e5f449698365
History
- no predecessors — first report